| 2′OMe | 2′-O-methyl |
| 2′MOE | 2′-O-methoxyethyl |
| AAV | Adeno-associated virus |
| AO | Antisense oligonucleotide |
| BMD | Becker muscular dystrophy |
| CFTR | Cystic fibrosis transmembrane conductance regulator |
| CyPA | Cyclophilin A |
| dKO | Double knock out |
| DM1 | Myotonic dystrophy type 1 |
| DMD | Duchenne muscular dystrophy |
| DMPK | Dystrophia myotonica protein kinase |
| DNA | Deoxyribonucleic acid |
| ESE | Exonic splicing enhancer |
| ESS | Exonic splicing silencer |
| FDA | Food and drug administration |
| GAA | Acid α-glucosidase |
| GFP | Green fluorescent protein |
| GRMD | Golden retriever muscular dystrophy |
| HD | Huntington’s disease |
| HDE | Histone downstream element |
| hDMD | Human DMD |
| HIV | Human immunodeficiency virus type 1 |
| hnRNPA1 | Heterogeneous nuclear ribonucleoprotein A1 |
| IM | Intramuscular |
| ISE | Intronic splicing enhancers |
| ISS | Intronic splicing silencers |
| IV | Intravenous |
| LNA | Locked nucleic acid |
| LV | Lentivirus |
| MBNL1 | Muscleblind-like protein 1 |
| MLV | Murine leukemia viruses |
| PMO | Phosphorodiamidate morpholino oligomers |
| PNA | Peptide nucleic acid |
| PPMO | Peptide phosphorodiamidate morpholino oligomers |
| rAAV | Recombinant Adeno-associated virus |
| RCL | replication competent lentiviruses |
| RCR | replication competent retroviruses |
| RNA | Ribonucleic acid |
| RYR1 | Type 1 ryanodine receptor |
| scAAV | Self-complementary adeno-associated virus |
| SMA | Spinal muscular atrophy |
| snRNA | Small nuclear RNA |
| snRNP | Small nuclear ribonucleoproteins |
| SR protein | Serine/arginine-rich protein |
| UTR | Untranslated transcribed region |
| VP | Viral protein |